SCHEMBL2199003

SCHEMBL2199003

COc1ccc(F)cc1OC[C@H]1CCCN1C(=O)OC(C)(C)C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRNB4 P30926 2/20 0.49
▸ CHRNA3 P32297 2/20 0.49
▸ ALOX5AP P20292 3/20 0.48
▸ FEN1 P39748 1/20 0.48
▸ F2RL3 Q96RI0 4/20 0.46
▸ APP P05067 1/20 0.45
▸ HTR1A P08908 1/20 0.45
▸ ADRA2A P08913 1/20 0.45
▸ DRD2 P14416 1/20 0.45
▸ ADRA2B P18089 1/20 0.45
▸ ADRA2C P18825 1/20 0.45
▸ SLC6A2 P23975 1/20 0.45
▸ HRH2 P25021 1/20 0.45
▸ HTR1D P28221 1/20 0.45
▸ HTR1B P28222 1/20 0.45
▸ HTR2A P28223 1/20 0.45
▸ HTR2C P28335 1/20 0.45
▸ HTR7 P34969 1/20 0.45
▸ DRD3 P35462 1/20 0.45
▸ OPRK1 P41145 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12431647 1.00 CHRNB4 (0.49) CHRNB4CHRNA3ALOX5APFEN1F2RL3
SCHEMBL2259269 0.90 ALOX5AP (0.49) ALOX5APFEN1F2RL3APPHTR1A
SCHEMBL17979996 0.90 ALOX5AP (0.47) ALOX5APFEN1F2RL3APPHTR1A
SCHEMBL2200755 0.89 CHRNB4 (0.58) CHRNB4CHRNA3ALOX5APFEN1F2RL3
SCHEMBL17980005 0.88 ALOX5AP (0.46) ALOX5APFEN1F2RL3APPHTR1A
SCHEMBL15500342 0.85 ALOX5AP (0.46) ALOX5APFEN1F2RL3APPHTR1A
SCHEMBL15300843 0.84 FPR3 (0.47) CHRNB4CHRNA3ALOX5APFEN1F2RL3
SCHEMBL15300841 0.84 FPR3 (0.47) CHRNB4CHRNA3ALOX5APFEN1F2RL3
SCHEMBL17980065 0.84 ALOX5AP (0.44) ALOX5APFEN1F2RL3APPHTR1A
SCHEMBL2200803 0.84 ALOX5AP (0.50) ALOX5APFEN1F2RL3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912994-B1 ADENINE DERIVATIVES MERCK PATENT GMBH (DE) 2014-03-12 — — EP disclosed
US-7977343-B2 Adenine derivatives MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-07-12 — — US disclosed
US-7977343-B2 Adenine derivatives MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-07-12 — — US disclosed
US-20100160352-A1 ADENINE DERIVATIVES MERCK PATENT GMBH (DE) 2010-06-24 — — US disclosed
US-20100160352-A1 ADENINE DERIVATIVES MERCK PATENT GMBH (DE) 2010-06-24 — — US disclosed
WO-2007017069-A1 ADENINE DERIVATIVES MERCK PATENT GMBH (DE) 2007-02-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160352-A1 ADENINE DERIVATIVES HSP90AA1, TRAP1, HSP90AB1 CHRNB4 4645/4885CHRNA3 3847/4885ALOX5AP 3894/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback